Fluorescence Characteristics and Lifetime Images of Photosensitizers of Talaporfin Sodium and Sodium Pheophorbide a in Normal and Cancer Cells
暂无分享,去创建一个
Kamlesh Awasthi | Liming Li | Nobuhiro Ohta | Kazuhito Yamamoto | Kazunari Furuya | Takakazu Nakabayashi | T. Nakabayashi | N. Ohta | Kazuhito Yamamoto | K. Awasthi | Liming Li | Kazunari Furuya
[1] Y. Nishiwaki,et al. New method of photosensitizer accumulation for photodynamic therapy in an experimental liver tumor , 1989, Lasers in surgery and medicine.
[2] H. Sasabe,et al. Discrimination of Normal and Cancer Cells From Autofluorescence Spectra by Laser Excitation , 2010 .
[3] T. Nakabayashi,et al. Sensing of Intracellular Environments by Fluorescence Lifetime Imaging of Exogenous Fluorophores , 2015, Analytical sciences : the international journal of the Japan Society for Analytical Chemistry.
[4] T. Iriuchishima,et al. Therapeutic effect of photodynamic therapy using Na-pheophorbide a on osteomyelitis models in rats. , 2011, Photomedicine and laser surgery.
[5] J. Franklin,et al. Rapid Activation of Antioxidant Defenses by Nerve Growth Factor Suppresses Reactive Oxygen Species during Neuronal Apoptosis: Evidence for a Role in Cytochrome c Redistribution , 2007, The Journal of Neuroscience.
[6] N. Ohta,et al. Time-resolved measurement system of electrofluorescence spectra , 2004 .
[7] S. Wang,et al. Talaporfin sodium , 2010, Expert opinion on pharmacotherapy.
[8] T. Iriuchishima,et al. Bactericidal effect of photodynamic therapy using Na-pheophorbide a: evaluation of adequate light source. , 2009, Photomedicine and laser surgery.
[9] Nobuhiro Ohta,et al. Intracellular pH sensing using autofluorescence lifetime microscopy. , 2011, The journal of physical chemistry. B.
[10] A. Harris,et al. How cancer metabolism is tuned for proliferation and vulnerable to disruption , 2012, Nature.
[11] R. Boyle,et al. Photodynamic therapy: novel third‐generation photosensitizers one step closer? , 2008, British journal of pharmacology.
[12] A. Krasnovsky,et al. Photophysical studies of pheophorbide a and pheophytin a. Phosphorescence and photosensitized singlet oxygen luminescence. , 1990, Journal of photochemistry and photobiology. B, Biology.
[13] M. Kobayashi,et al. Mechanism of photodynamic activity of pheophorbides. , 2001, Journal of biomedical optics.
[14] T. Joh,et al. Anticancer effects of novel photodynamic therapy with glycoconjugated chlorin for gastric and colon cancer. , 2011, Anticancer research.
[16] Koichi Saito,et al. Phase-resolved fluorescence study of mono-L-aspartyl chlorin E6. , 2002, Journal of photochemistry and photobiology. B, Biology.
[17] A. Molinari,et al. Microenvironmental pH Is a Key Factor for Exosome Traffic in Tumor Cells* , 2009, The Journal of Biological Chemistry.
[18] D. Kessel,et al. Effects of the Oxygenation Level on Formation of Different Reactive Oxygen Species During Photodynamic Therapy , 2013, Photochemistry and photobiology.
[19] Raymond Bonnett,et al. Photosensitizers of the porphyrin and phthalocyanine series for photodynamic therapy , 1995 .
[20] Manivannan Ethirajan,et al. The role of porphyrin chemistry in tumor imaging and photodynamic therapy. , 2011, Chemical Society reviews.
[21] Hirofumi Kawabe,et al. LOCALIZATION OF MONO‐L‐ASPARTYL CHLORIN e6 (NPe6) IN MOUSE TISSUES , 1987, Photochemistry and photobiology.
[22] Tomonori Yano,et al. Phase I study of photodynamic therapy using talaporfin sodium and diode laser for local failure after chemoradiotherapy for esophageal cancer , 2012, Radiation oncology.
[23] J D Spikes,et al. Photosensitizing properties of mono-L-aspartyl chlorin e6 (NPe6): a candidate sensitizer for the photodynamic therapy of tumors. , 1993, Journal of photochemistry and photobiology. B, Biology.
[24] E J BALDES,et al. The photodynamic properties of a particular hematoporphyrin derivative. , 1960, Archives of dermatology.
[25] S. Achilefu,et al. Fluorescence lifetime measurements and biological imaging. , 2010, Chemical reviews.
[26] Matthew P. Jacobson,et al. Dysregulated pH: a perfect storm for cancer progression , 2011, Nature Reviews Cancer.
[27] T. Chiba,et al. Preclinical Validation of Talaporfin Sodium-Mediated Photodynamic Therapy for Esophageal Squamous Cell Carcinoma , 2014, PloS one.
[28] M. Beppu,et al. Photodynamic therapy in combination with talaporfin sodium induces mitochondrial apoptotic cell death accompanied with necrosis in glioma cells. , 2013, Biological & pharmaceutical bulletin.
[29] Masaaki Kawahara,et al. Phase II clinical study of photodynamic therapy using mono-L-aspartyl chlorin e6 and diode laser for early superficial squamous cell carcinoma of the lung. , 2003, Lung cancer.
[30] T. Delaney,et al. Photodynamic therapy of cancer. , 1988, Comprehensive therapy.
[31] J. Usuda,et al. Photodynamic therapy for lung cancers based on novel photodynamic diagnosis using talaporfin sodium (NPe6) and autofluorescence bronchoscopy. , 2007, Lung cancer.
[32] B. Liu,et al. Detection and analysis of reactive oxygen species (ROS) generated by nano-sized TiO2 powder under ultrasonic irradiation and application in sonocatalytic degradation of organic dyes. , 2011, Ultrasonics sonochemistry.
[33] Sang‐Gun Ahn,et al. Pheophorbide a-mediated photodynamic therapy induces apoptotic cell death in murine oral squamous cell carcinoma in vitro and in vivo. , 2012, Oncology reports.
[34] D. Xing,et al. Cell death via mitochondrial apoptotic pathway due to activation of Bax by lysosomal photodamage. , 2011, Free radical biology & medicine.